The number of new cases in the US rose last week at the slowest pace since the pandemic began, as more Americans are vaccinated and the nation recovers from a winter spike fuelled by holiday travel. The total number of new infections was the lowest since September.
In New York, free subway and train rides are being offered to those who get shots at city mass-transit terminals.
In Europe, the UK lowered its alert level and confirmed plans to allow indoor mixing from May 17, while the Czech Republic opened all shops, museums and galleries. BioNTech raised its Covid-19 vaccine sales estimate for 2021 to €12.4-billion as countries ramp up their inoculation campaigns. Earlier, the company selected Singapore as its Southeast Asia headquarters.
https://www.afinalwarning.com/512206.html (Natural News) Norway’s health agency has recommended that the country permanently abort using the AstraZeneca Wuhan coronavirus vaccine. The recommendation came after Norwegian scientists found that the vaccine, made in partnership with the
University of Oxford, did cause blood clots. The agency’s advice went contrary to guidance from other health authorities and regulators insisting on the vaccine’s safety.
Norwegian Institute of Public Health (NIPH) Director Geir Bukholm said in an April 15 statement: “There is now significantly more knowledge about the connection between the AstraZeneca vaccine and the rare and serious incidents of low platelets, blood clots and bleeding,” he remarked. Bukholm added that “based on this knowledge, we have arrived at a recommendation that the AstraZeneca vaccine be removed from the coronary vaccination program in Norway.”
AstraZeneca vaccine: Norway and Denmark researchers show an increased rate of rare but serious blood clots in the brain and venous blood clots
Home » Vaccines » AstraZeneca vaccine: Norway and Denmark researchers show an increased rate of rare but serious blood clots in the brain and venous blood clots AstraZeneca vaccine: Norway and Denmark researchers show an increased rate of rare but serious blood clots in the brain and venous blood clots
Following the initial reports of rare side effects after vaccination with the AstraZeneca vaccine (Vaxevria), a registry study was initiated quickly. The study includes over 281,000 people who have received this vaccine in Norway and Denmark. It is the first study to systematically investigate the occurrence of side effects in the cardiovascular system after vaccination.
›New study finds slightly increased rates of vein blood clots after AstraZaneca Covid vaccine; stresses risk of adverse events low
New study finds slightly increased rates of vein blood clots after AstraZaneca Covid vaccine; stresses risk of adverse events low
SECTIONS
New study finds slightly increased rates of vein blood clots after AstraZaneca Covid vaccine; stresses risk of adverse events lowPTI
Last Updated: May 07, 2021, 05:35 PM IST
Share
Synopsis
The findings are based on 280,000 people aged 18-65 who received a first dose of the Oxford-AstraZeneca vaccine.
iStock
Related
NEW DELHI: A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19 vaccine, compared with expected rates in the general population. However, the study published in The BMJ on Wednesday, stresses that the risk of such adverse events is considered low.